These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8273373
1. [Interferon therapy in hepatitis C]. Ferenci P. Wien Med Wochenschr; 1993; 143(16-17):461-4. PubMed ID: 8273373 [Abstract] [Full Text] [Related]
4. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C. Glück T, Seelig R, Dette S, Bühring HJ, Renz M, Kwon S, Wiedmann KH, Weber P. Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523 [Abstract] [Full Text] [Related]
5. Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatment. Halpern Z, Arber N, Hallak A, Konikoff F, Santo M, Moshkowitz M, Tomny E, Gilat T. Isr J Med Sci; 1995 Jun; 31(6):341-4. PubMed ID: 7607851 [Abstract] [Full Text] [Related]
6. alpha-Interferon retreatment of patients with chronic hepatitis C. Rabinovitz M, Block G, Finkelstein SD. Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654 [Abstract] [Full Text] [Related]
9. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment. Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G. Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022 [Abstract] [Full Text] [Related]
10. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C]. Moulin V, Harzic M, Doll J, Dubeaux B, Ghnassia JC, Andrieu J. Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497 [Abstract] [Full Text] [Related]
12. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C. Ueno T, Inuzuka S, Sata M, Koh H, Tamaki S, Kin M, Sugawara H, Sakata R, Torimura T, Tanikawa K. Hepatogastroenterology; 1995 May; 42(5):522-7. PubMed ID: 8751209 [Abstract] [Full Text] [Related]
13. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction. Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY. Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145 [Abstract] [Full Text] [Related]
14. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination]. Glück T, Dürk H, Kötter I, Zimmermann C, Saal JG. Med Klin (Munich); 1995 Dec 15; 90(12):674-80. PubMed ID: 8583982 [Abstract] [Full Text] [Related]
18. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives]. Marcellin P, Pouteau M, Martinot M, Boyer N, Castelnau C, Benhamou JP, Erlinger S. Gastroenterol Clin Biol; 1995 Dec 20; 19(12):991-1000. PubMed ID: 8729410 [No Abstract] [Full Text] [Related]
19. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug 20; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]